Cardiol Therapeutics Inc. (CRDL)
Develops drug treatments to reduce inflammation and scarring in damaged hearts.
$1.20+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-13.0%
The outlook
CRDL is trading at $1.20, positioned in the lower-middle portion of its 52-week range and above both its 50- and 200-day moving averages. Analyst consensus is Strong Buy with an average price target significantly above the current level. The stock's technical positioning and analyst sentiment both register as notably bullish.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range39% of the way from its 52-week low to high
Price targetAvg target +512% vs current price
Analyst price target
~12-month · 4 analysts$7.35average target+512.2% vs now
Now $1.20
Low $4.87High $9.01
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$138.3M
52-wk high
$1.71
52-wk low
$0.88
50-day avg
$1.14
200-day avg
$1.12
Trailing P/E
—